In people with chronic obstructive pulmonary disease (COPD), the ability of the heart both to beat faster during physical…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Cipla has launched Spirofy — its wireless, portable device capable of performing lung function tests outdoors and in remote…
A combination of antibiotics may be more effective at killing harmful bacteria in the lungs of people with chronic…
A protein called ABCC1 lets a specific signaling molecule leak out of muscle cells in the airways, which may contribute…
Seven days of treatment with ensifentrine, given using a pressurized metered-dose inhaler — called a pMDI — resulted in marked…
A mucus protein called MUC5AC may contribute to the abnormally thick and sticky mucus that develops in people with…
Two additional Blue Cross Blue Shield (BCBS) plans are now covering Pulmonx’s Zephyr Endobronchial Valve and similar devices to treat…
Renovion is teaming up with the COPD Foundation to develop a new nebulized therapy that aims to help…
Noninvasive ventilation at home, known as NIVH, can reduce the risk of hospitalization, emergency department visits, and death in people…
A $12.8 million five-year renewal grant from the National Institutes of Health (NIH) will fund research that seeks to better…